#MCL1
Last but not least for this session, we welcome Ahmed Elshazly from Virgina Commonwealth University, presenting his work on “AUTAC-mediated selective autophagy uncouples MCL1-targeted antitumor activity from cardiotoxicity”.

#WIA2026meeting
October 28, 2026 at 12:37 AM
Giorgia Giordano, Olivia Arnold, Diren Arda Karaoglu, Jommel Macaraeg, Kathryn Shimamoto, Arjun Dhar, Ella Postich, Hamed R Youshanlouei, Sinan Cetin, Girish Venkataraman, Anand A Patel, Adam DuVall, Michael W Drazer, David T Teachey, James L LaBelle, Wendy Stock, and Caner Saygin
MCL1 inhibition exerts potent antileukemic activity by restoring apoptosis in T-lineage acute lymphoblastic leukemia
No abstract
linkinghub.elsevier.com
October 18, 2026 at 4:00 PM
Covalent drug discovery targets cysteine because the chemistry works there, not because the targets are there. The Baker Group at UW used an EBA warhead to capture lysine irreversibly – 61-fold more potent against MCL1.

americanpeptidesociety.org/research/lys...
October 14, 2026 at 3:30 PM
Infection and hypoxic stress converge on the PHD1–TRIM21–CDC20 axis, promoting CDC20 degradation and securin and MCL1 accumulation to drive cancer cell #Aneuploidy and #Chemoresistance.
#STTT #OpenAccess: doi.org/10.1038/s413...
October 3, 2026 at 6:30 AM
PXD082999 🚨

Transiently over-expressing TurboID-MCL1 (human, full-length) or the negative control TurboIDGFP were subjected to a proximity biotinylation workflow and enrichment to identify MCL1-specific interactors in live cells.

🚨 New dataset alert! 🚨
September 29, 2026 at 11:00 AM
Mitochondrial priming in human germ cell tumors is dependent on MCL1 and BCL2L1 https://www.biorxiv.org/content/10.64898/2026.09.22.752028v1
September 26, 2026 at 10:45 AM
Mitochondrial priming in human germ cell tumors is dependent on MCL1 and BCL2L1 https://www.biorxiv.org/content/10.64898/2026.09.22.752028v1
September 26, 2026 at 10:45 AM
glad to be a part of this effort led by @canersaygin.bsky.social looking at the potential therapeutic role of MCL1 inhibition in T-cell ALL

www.sciencedirect.com/science/arti...
September 16, 2026 at 3:57 AM
#Infection and #Hypoxia converge on the PHD1–TRIM21–CDC20 axis to drive #Aneuploidy and #Chemoresistance, while CDC20 stabilization limits securin and MCL1 accumulation, reduces chromosomal imbalance, and restores #Chemosensitivity.

#STTT #OpenAccess: doi.org/10.1038/s413...
September 8, 2026 at 7:00 AM
Authors used Abcam HEK293T MCL1 K from @cellosaurus.bsky.social in their study. Including #RRIDs will make this less ambiguous.

SciScore made a table with this resource, see “Automated Services” module (download as csv, xml or #jats) #reproducibility #RRID
www.biorxiv.org
August 27, 2026 at 12:00 PM
Great back-to-back papers in @natcomms.nature.com
tinyurl.com/3dp98bke
tinyurl.com/wy9ychb2
on MCL1 as a novel therapeutic target in CIC::DUX #sarcomas

These cancers remain challenging (tinyurl.com/kz4h8rws) but these studies spark hope! Glad that our division @dkfz.bsky.social could contribute!
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target - Nature Communications
Despite their differences, the rarer sarcoma CIC::DUX4 sarcoma (CDS) is typically treated with therapies developed for Ewing Sarcoma (EwS) with limited success. Here, the authors develop a co-clinical...
tinyurl.com
August 23, 2025 at 5:12 AM
Authors identify MCL1 as a promising therapeutic target in pediatric HGG, offering a translational strategy to identify patients that may benefit from MCL1 inhibitor therapy. https://insight.jci.org/articles/view/184601
January 27, 2025 at 5:20 PM
Mcl1 as a Molecular Switch Linking Inflammatory Bowel Diseases to Colorectal Tumorigenesis.
Mcl1 as a Molecular Switch Linking Inflammatory Bowel Diseases to Colorectal Tumorigenesis.
Published in Biomolecules
doi.org
May 27, 2026 at 1:00 PM
Interferon-stimulated gene MCL1 inhibits foot-and-mouth disease virus replication by modulating mitochondrial dynamics and autophagy journals.asm.org/doi/10.1128/...
Interferon-stimulated gene MCL1 inhibits foot-and-mouth disease virus replication by modulating mitochondrial dynamics and autophagy | Journal of Virology
In this study, we have successfully used a high-throughput ISG screening approach to measure the inhibition of FMDV replication using an RNA replicon system for the first time. This screen led to the identification of the potent antiviral effects of a ...
journals.asm.org
June 4, 2025 at 3:45 PM
Multiple myeloma patients with chromosome 1q+ show promising sensitivity to MCL1 and PI3K inhibitors, enhancing targeted therapy potential.

by Sklavenitis-Pistofidis R, Lightbody ED (...) Manier S et 24 al. in Blood #MedSky

👉 get more here

📖 read the article:
Large-scale dependency and drug screens to characterize the therapeutic vulnerabilities of multiple myeloma with 1q+
Key PointsWe leveraged large-scale genetic dependency screens and drug screens to characterize the therapeutic vulnerabilities of MM with 1q+.We showed tha
ashpublications.org
July 12, 2025 at 2:27 AM
degrading mcl1 via autophagy. the 'cellular recycling' framing feels a touch loud for that.
July 14, 2026 at 11:03 AM
onlinelibrary.wiley.com/doi/10.1111/...
🧪
Really great review highlights the importance of integrating DNA, RNA and protein-level analyses to deepen the understanding of AL amyloidosis pathogenesis.
The molecular landscape of AL amyloidosis
Within the bone marrow, the clonal plasma cell population exhibits an abnormal expression of non-coding RNAs, which, in turn, upregulates anti-apoptotic genes (BCL2, MCL1, BCL2L1), leading to an anti...
onlinelibrary.wiley.com
May 6, 2025 at 10:41 AM
Online now: Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival program
Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival program
Ding et al. show that allergy-associated IgE plasma cells exhibit limited accrual in the bone marrow, instead residing in other tissues for extended periods. These long-lived cells are rare and sensitive to navitoclax rather than deletion of the anti-apoptotic protein MCL1, which effectively kills other plasma cells.
dlvr.it
November 4, 2025 at 3:49 PM
Researchers @tudresden.bsky.social found that a protein called MCL1, previously known for helping #cancer cells survive, also affect the heart in #mice.
www.eara.eu/post/cancer-...
#cancer #heart #mice #research #researchnews #health #AnimalResearch #Germany
Cancer protein affects the heart in mice
A study in Germany using mice has revealed that a protein linked to cancer also affects the heart.
www.eara.eu
January 15, 2026 at 2:02 PM